Cargando…
Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKKβ/NF-κB signaling pathway in lung cancer cells
BACKGROUND: Gamabufotalin (CS-6), a major bufadienolide of Chansu, has been used for cancer therapy due to its desirable metabolic stability and less adverse effect. However, the underlying mechanism of CS-6 involved in anti-tumor activity remains poorly understood. METHODS: The biological functions...
Autores principales: | Yu, Zhenlong, Guo, Wei, Ma, Xiaochi, Zhang, Baojing, Dong, Peipei, Huang, Lin, Wang, Xiuli, Wang, Chao, Huo, Xiaokui, Yu, Wendan, Yi, Canhui, Xiao, Yao, Yang, Wenjing, Qin, Yu, Yuan, Yuhui, Meng, Songshu, Liu, Quentin, Deng, Wuguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161895/ https://www.ncbi.nlm.nih.gov/pubmed/25175164 http://dx.doi.org/10.1186/1476-4598-13-203 |
Ejemplares similares
-
Correction: Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKKβ/NF-κB signaling pathway in lung cancer cells
por: Yu, Zhenlong, et al.
Publicado: (2023) -
Gamabufotalin, a major derivative of bufadienolide, inhibits VEGF-induced angiogenesis by suppressing VEGFR-2 signaling pathway
por: Tang, Ning, et al.
Publicado: (2015) -
Gamabufotalin triggers c-Myc degradation via induction of WWP2 in multiple myeloma cells
por: Yu, Zhenlong, et al.
Publicado: (2016) -
Quantitative proteomics reveals molecular mechanism of gamabufotalin and its potential inhibition on Hsp90 in lung cancer
por: Zhang, Liyuan, et al.
Publicado: (2016) -
Toad venom-derived bufadienolides and their therapeutic application in prostate cancers: Current status and future directions
por: Ye, Qingmei, et al.
Publicado: (2023)